Parkinson’s disease-related protein Parkin may rely on another protein called MITOL to repair damaged mitochondria, the small organelles…
Catarina Silva, MSc
With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Catarina Silva, MSc
Connexin-32 — a protein found in small channels between nerve cells and involved in cell-to-cell communication — works to progress …
Chrysin, a chemical commonly found in plants, may ease behavioral, cognitive, and neurochemical changes in Parkinson’s disease, according to…
One amino acid change in the brain-derived neurotrophic factor (BDNF) gene, which provides instructions for a protein important to…
Intensive singing interventions have the potential to increase vocal loudness, respiratory muscle strength, and voice-related quality of life in people…
A wearable device called Personal KinetiGraph (PKG) can continuously and objectively monitor motor symptoms in people with Parkinson’s…
#AANAM – Promising Blood Pressure Medicine Fails to Slow Parkinson’s Progression, Trial Results Show
In contrast to what was observed in mice, a hypertension medicine called Dynacirc (isradipine) failed to slow Parkinson’s disease…
Impel NeuroPharma has developed an inhaler to administrate a powder formulation of levodopa (L-DOPA) so people with…
Treatment with Intranasal Insulin May Improve Verbal Fluency and Motor Function, Early Study Shows
Treatment with intranasal insulin — which is atomized into a spray and inhaled through the nose — may ease…
Patient enrollment and dosing is now complete for International Stem Cell Corporation’s (ISCO) Phase 1 trial testing its ISC-hpNSC…